HSP90AA1 and osteosarcoma: The inhibition of HSP90AA1 restores the sensitivity to chemotherapy in osteosarcoma cells through the reduction of autophagy via the PI3K/AKT/mTOR pathway and the induction of apoptosis via the JNK/P38 pathway [113].